Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Login
Google Translate
Select language
English
French
Spanish
Login
Username
*
Password
*
Staff Login
×
Google Translate
Select language
English
French
Spanish
Login
Menu
Site Search
Search Options
Resources
Everything
Advanced Search
Uptodate
All
Title Search
Author
Patients & Caregivers
Healthcare Providers
Researchers & Partners
Investors
menu
About Us
Life Sciences Publications
Our Medicines
Topic Articles
Topic Discussions
Patents
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
LC-MS/MS method for the determination of the prodrug aripiprazole lauroxil and its three metabolites in plasma and its application to in vitro biotransformation and animal pharmacokinetic studies
Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine
Newron Pharmaceuticals to Present at the 20th Annual BIO CEO & Investor Conference in New York
Auris Medical Holding Ag Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Jan. 29, 2018)
Auris Medical Holding Ag Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Jan. 29, 2018)
Deals Shaping The Medical Industry, February 2018
Managing Behavioral and Psychological Symptoms of Dementia
Research report: Hippocampal GABAA antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated rats
IDOXURIDIN UND DESSEN ANALOGA ALS NEUROPROTEKTIVA ZUR BEHANDLUNG VON PARKINSONISMUS
IQWiG: ‘Quality’ Registry Data Suitable for Benefit Assessments
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »
×